Gyno-Pevaryl (Econazole Nitrate)

Gyno-Pevaryl is indicated for the treatment of fungal infections of the vagina, with a primary focus on managing vulvovaginal candidiasis caused by Candida species.

• Topical therapy for acute episodes of vulvovaginal candidiasis.
• Adjunctive treatment for recurrent Candida infections when systemic therapy is not required.
• Management of mild to moderate vaginal yeast infections confirmed by clinical assessment.
• Use in patients seeking a locally acting antifungal without oral medication.

Possible adverse effects of Gyno-Pevaryl are generally mild and related to local application, though rare serious reactions can occur.

Common

• Mild vaginal irritation or burning sensation.
• Itching or mild pruritus in the treated area.
• Transient vaginal discharge or spotting.
• Local dryness or discomfort.

Serious

• Allergic reaction presenting as rash, swelling, or hives.
• Severe vaginal inflammation or ulceration.

Before using Gyno-Pevaryl, certain precautions should be considered to ensure safe and effective treatment.

• Confirm diagnosis of vulvovaginal candidiasis before initiating therapy.
• Avoid use if known hypersensitivity to econazole nitrate or other imidazole antifungals.
• Do not use in the presence of active vaginal bleeding or severe irritation.
• Pregnancy and lactation status should be discussed with a healthcare professional.
• If symptoms persist beyond the recommended treatment period, seek medical advice.
• Do not insert the product deeper than recommended to avoid uterine exposure.

Gyno-Pevaryl may interact with other medications or products applied vaginally, and certain combinations should be avoided or used with caution.

Avoid

• Concurrent use of other intravaginal antifungal or antiseptic agents.
• Combination with vaginal spermicides or lubricants containing irritants.
• Simultaneous application of hormonal vaginal tablets or rings without medical guidance.

Use with caution

• Topical antibiotics that may alter vaginal flora.
• Systemic antifungal therapy; monitor for overlapping toxicity.
• Use with estrogen replacement therapy; assess for potential irritation.